Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Populations of RNA molecules as computational model for evolution

  • Stich, Michael
  • Briones, Carlos
  • Lázaro, Ester
  • Manrubia Cuevas, Susanna
Pontarotti P. (eds).-- Presents the most representative contributions to the 13th Evolutionary Biology Meeting in Marseille., We consider populations of RNA molecules as computational model for molecular evolution. Based on a large body of previous work, we review some recent results. In the first place, we study the sequence–structure map, its implications on the structural repertoire of a pool of random RNA sequences and its relevance for the RNA world hypothesis of the origin of life. In a scenario where template replication is possible, we discuss the internal organization of evolving populations and its relationship with robustness and adaptability. Finally, we explore how the effect of the mutation rate on fitness changes depends on the degree of adaptation of an RNA population., The authors acknowledge support from Spanish MICIIN through projects FIS2008-05273 and BIO2007-67523, from INTA, and from Comunidad Autónoma de Madrid, project MODELICO (S2009/ESP-1691)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Genomic Analysis of Bacterial Outbreaks

  • Sánchez-Busó, Leonor
  • Comas, Iñaki
  • Beamud, Beatriz
  • García-González, Neris
  • Pla, Marta
  • González-Candelas, Fernando
European Research Council (ERC) (638553-TB-ACCELERATE), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Genomic Epidemiology of Tuberculosis

  • Comas, Iñaki
Gagneux, S. (ed) .-- 16 páginas, The application of next generation sequencing technologies has opened the door to a new molecular epidemiology of tuberculosis, in which we can now look at transmission at a resolution not possible before. At the same time, new technical and analytical challenges have appeared, and we are still exploring the wider potential of this new technology. Whole genome sequencing in tuberculosis still requires bacterial cultures. Thus, although whole genome sequencing has revolutionized the interpretation of transmission patterns, it is not yet ready to be applied at the point-of-care. In this chapter, I will review the promises and challenges of genomic epidemiology, as well as some of the new questions that have arisen from the use of this new technology. In addition, I will examine the role of molecular epidemiology within the general frame of global tuberculosis control and how genomic epidemiology can contribute towards the elimination of the disease., Work in my laboratory is supported by the Spanish National Foundation (MINECO SAF2013-43521-R) and the European Research Council (638553-TB-ACCELERATE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues

  • Meehan, Conor J.
  • Goig, Galo A.
  • Kohl, Thomas A.
  • Verboven, Lennert
  • Dippenaar, Anzaan
  • Ezewudo, Matthew
  • Farhat, Maha R.
  • Guthrie, Jennifer L.
  • Laukens, Kris
  • Miotto, Paolo
  • Ofori-Anyinam, Boatema
  • Dreyer, Viola
  • Supply, Philip
  • Suresh, Anita
  • Utpatel, Christian
  • van Soolingen, Dick
  • Zhou, Yang
  • Ashton, Philip M.
  • Brites, Daniela
  • Cabibbe, Andrea M.
  • de Jong, Bouke C.
  • de Vos, Margaretha
  • Menardo, Fabrizio
  • Gagneux, Sebastien
  • Gao, Qian
  • Heupink, Tim H.
  • Liu, Qingyun
  • Loiseau, Chloé
  • Rigouts, Leen
  • Rodwell, Timothy C.
  • Tagliani, Elisa
  • Walker, Timothy M.
  • Warren, Robin M.
  • Zhao, Yanlin
  • Zignol, Matteo
  • Schito, Marco
  • Gardy, Jennifer
  • Cirillo, Daniela M.
  • Niemann, Stefan
  • Comas, Iñaki
  • Van Rie, Annelies
13 páginas, 4 figuras. Contiene material suplementario., Whole genome sequencing (WGS) of Mycobacterium tuberculosis has rapidly progressed from a research tool to a clinical application for the diagnosis and management of tuberculosis and in public health surveillance. This development has been facilitated by drastic drops in cost, advances in technology and concerted efforts to translate sequencing data into actionable information. There is, however, a risk that, in the absence of a consensus and international standards, the widespread use of WGS technology may result in data and processes that lack harmonization, comparability and validation. In this Review, we outline the current landscape of WGS pipelines and applications, and set out best practices for M. tuberculosis WGS, including standards for bioinformatics pipelines, curated repositories of resistance-causing variants, phylogenetic analyses, quality control and standardized reporting., C.J.M., B.O.-A., L.R. and B.C.d.J. are supported by a European Research Council grant (INTERRUPTB; no. 311725). I.C. and G.A.G. are supported by a European Research Council grant (TB-ACCELERATE; no. 638553). T.C.R. receives salary support from the not-for-profit organization Foundation for Innovative New Diagnostics (the terms of this arrangement have been reviewed and approved by the University of California, San Diego). T.M.W. is an NIHR Academic Clinical Lecturer. J.L.G. and J.G. receive funding from the University of British Columbia, Vancouver, Canada. T.A.K., C.U., V.D. and S.N. receive funding from the German Center for Infection Research (DZIF) and are funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany’s Excellence Strategy (EXC 22167–390884018). L.V., T.H.H. and A.V.R. are funded by FWO Odysseus G0F8316N. M.R.F. is supported by the US National Institutes of Health BD2K K01 (MRF ES026835). P.S. is supported by the Agence Nationale de la Recherche (ANR-16-CE35-0009)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020

  • Hodcroft, Emma B.
  • Zuber, Moira
  • Nadeau, Sarah
  • Comas, Iñaki
  • González-Candelas, Fernando
  • Seqcovid-Spain Consortium
  • Stadler, Tanja
  • Neher, Richard A.
A variant of SARS-CoV-2 emerged in early summer 2020, presumably in Spain, and has since spread to multiple European countries. The variant was first observed in Spain in June and has been at frequencies above 40% since July. Outside of Spain, the frequency of this variant has increased from very low values prior to 15th July to 40-70% in Switzerland, Ireland, and the United Kingdom in September. It is also prevalent in Norway, Latvia, the Netherlands, and France. Little can be said about other European countries because few recent sequences are available. Sequences in this cluster (20A.EU1) differ from ancestral sequences at 6 or more positions, including the mutation A222V in the spike protein and A220V in the nucleoprotein. We show that this variant was exported from Spain to other European countries multiple times and that much of the diversity of this cluster in Spain is observed across Europe. It is currently unclear whether this variant is spreading because of a transmission advantage of the virus or whether high incidence in Spain followed by dissemination through tourists is sufficient to explain the rapid rise in multiple countries., This work was supported by the SNF through grant numbers 31CA30 196046 (to RAN, EBH) and 31CA30 196267 and core funding by the University of Basel. SeqCOVID-SPAIN is funded by the Instituto de Salud Carlos III project COV20/00140, Spanish National Research Council and ERC StG 638553 to IC., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

The first wave of the Spanish COVID-19 epidemic was associated with early introductions and fast spread of a dominating genetic variant

  • López, Mariana G.
  • Chiner-Oms, Álvaro
  • García de Viedma, Darío
  • Ruiz-Rodríguez, Paula
  • Bracho, María Alma
  • Cancino-Muñoz, Irving
  • D’Auria, Giuseppe
  • Marco, Griselda de
  • García-González, Neris
  • Goig, Galo A.
  • Gómez-Navarro, Inmaculada
  • Jiménez-Serrano, Santiago
  • Martínez-Priego, Llucia
  • Ruiz-Hueso, Paula
  • Ruiz-Roldán, Lidia
  • Torres-Puente, Manuela
  • Alberola, Juan
  • Albert, Eliseo
  • Aranzamendi Zaldumbide, Maitane
  • Bea-Escudero, María Pilar
  • Boga, José Antonio
  • Bordoy, Antoni E.
  • Canut, Andrés
  • Carvajal, Ana
  • Cilla Eguiluz, Gustavo
  • Cordón Rodríguez, María Luz
  • Costa-Alcalde, José J.
  • Toro, María de
  • Toro Peinado, Inmaculada de
  • Pozo, José Luis del
  • Duchêne, Sebastián
  • Fernández-Pinero, Jovita
  • Fuster Escrivá, Begoña
  • Gimeno, Concepción
  • González Galán, Verónica
  • Gonzalo Jimeno, Nieves
  • Hernáez Crespo, Silvia
  • Herranz, Marta
  • Lepe, José A.
  • López-Hontangas, José Luis
  • Marcos, María Ángeles
  • Martín, Vicente
  • Martró, Elisa
  • Milagro Beamonte, Ana
  • Montes Ros, Milagrosa
  • Moreno-Muñoz, Rosario
  • Navarro, David
  • Navarro-Marí, José María
  • Not, Anna
  • Oliver, Antonio
  • Palop-Borrás, Begoña
  • Parra Grande, Mónica
  • Pedrosa-Corral, Irene
  • Pérez González, María Carmen
  • Pérez-Lago, Laura
  • Piñeiro Vázquez, Luis
  • Rabella, Nuria
  • Reina, Jordi
  • Rezusta, Antonio
  • Robles Fonseca, Lorena
  • Rodríguez-Villodres, Ángel
  • Sanbonmatsu-Gámez, Sara
  • Sicilia, Jon
  • Tirado Balaguer, María Dolores
  • Torres, Ignacio
  • Tristancho, Alexander
  • Marimón, José María
  • Coscollá, Mireia
  • González-Candelas, Fernando
  • Comas, Iñaki
The COVID-19 pandemic has shaken the world since the beginning of 2020. Spain is among the European countries with the highest incidence of the disease during the first pandemic wave. We established a multidisciplinar consortium to monitor and study the evolution of the epidemic, with the aim of contributing to decision making and stopping rapid spreading across the country. We present the results for 2170 sequences from the first wave of the SARS-Cov-2 epidemic in Spain and representing 12% of diagnosed cases until 14th March. This effort allows us to document at least 500 initial introductions, between early February-March from multiple international sources. Importantly, we document the early raise of two dominant genetic variants in Spain (Spanish Epidemic Clades), named SEC7 and SEC8, likely amplified by superspreading events. In sharp contrast to other non-Asian countries those two variants were closely related to the initial variants of SARS-CoV-2 described in Asia and represented 40% of the genome sequences analyzed. The two dominant SECs were widely spread across the country compared to other genetic variants with SEC8 reaching a 60% prevalence just before the lockdown. Employing Bayesian phylodynamic analysis, we inferred a reduction in the effective reproductive number of these two SECs from around 2.5 to below 0.5 after the implementation of strict public-health interventions in mid March. The effects of lockdown on the genetic variants of the virus are reflected in the general replacement of preexisting SECs by a new variant at the beginning of the summer season. Our results reveal a significant difference in the genetic makeup of the epidemic in Spain and support the effectiveness of lockdown measures in controlling virus spread even for the most successful genetic variants. Finally, earlier control of SEC7 and particularly SEC8 might have reduced the incidence and impact of COVID-19 in our country., This work was funded by the Instituto de Salud Carlos III project COV20/00140, Spanish 593 National Research Council project CSIC-COV19-021 and ERC StG 638553 to IC, and BFU2017- 594 89594R to FGC. MC is supported by Ramón y Cajal program from Ministerio de Ciencia and 595 grants RTI2018-094399-A-I00 and SEJI/2019/011. 596 We gratefully acknowledge Hospital Universitari Vall d'Hebron, Instituto de Salud Carlos 597 III, IrsiCaixa AIDS Research Lab and all the international researchers and institutions that 598 submitted sequenced SARS-CoV-2 genomes to the GISAID’s EpiCov™ Database, as an 599 important part of our analyses have been made possible by the share of their work., No